Advanced search
Publication Cover
Scandinavian Journal of Infectious Diseases Volume 32, 2000 - Issue 1
Submit an article Journal homepage
6
Views
12
CrossRef citations to date
0
Altmetric
Research Article

Metronidazole and Clarithromycin Susceptibility and the Subtypes of VacA of Helicobacter pylori Isolates in Estonia

Krista Lõivukene, Helgi Kolk, Heidi-Ingrid Maaroos, Priit Kasenõmm, Helena Aro, Mart Ustav, Marika Mikelsaar Department of Microbiology, Ravila Str. 19, Tartu EE-51014, Estonia
Pages 59-62 | Published online: 08 Jul 2009

References

  • Blaser MJ. H. pylori: its role in disease. Clin Inf Dis 1992; 15: 386–93.
  • Mikelsaar M, Kolts K, Maaroos H-I. Microbial ecology of H. pylori in antral gastritis and peptic ulcer disease. Microbiol Ecol Health Disease 1990; 3: 245–50.
  • Arnold R, Quina M. Peptic ulcer pathogenesis. Curr Opin Gastroenterol 1996; 12: 24–7.
  • Parsonnet J, Friedman GD. H. pylori infection and risk of gastric carcinoma. N Engl J Med 1991; 25: 1127–31.
  • Megraud F, Doermann HP. Clinical relevance of resistant strains of Helicobacter pylori: a review of current data. Gut 1998; 43: 61S–5S.
  • Van der Hulst RWM, van der Ende A, Homan A, Roorda P, Dankert J, Tytgat GNJ. Influence of metronidazole resistance on efficacy of quadruple therapy for H. pylori eradication. Gut 1998; 42: 166–9.
  • Raymond J, Kalach N, Bergert M, et al. Effect of metronidazole resistance on bacterial eradication of H. pylori in infected children. Antimicrob Ag Chemother 1998; 6: 1334–5.
  • Megraud F. Resistance of H. pylori to antibiotics. Aliment Pharmacol Ther 1997; 11: 43–53.
  • Weel JFL, van der Hulst RWM, Gerrits Y, Tytgat GNJ, van der Ende A, Dankert J. Heterogeneity in susceptibility to metronidazole among H. pylori isolates from patients with gastritisor peptic ulcerdisease. J Clin Microbiol 1996;9:2158–62.
  • van der Wouden EJ, de Jong A, Thijs JC, Kleibeuker JH, wan Zweit AA. Subpopulations of Helicobacter pylori are responsible for discrepansies in the outcome of nitroimidazole susceptibility testing. Antimicrob Ag Chemother 1999; 6: 1484–6.
  • Smith MA, Edwards DI. Oxygen scavening, NADH oxidase and metronidazole resistance in H. pylori. J Antimicrob Chemother 1997; 39: 347–53.
  • Iovene MR, Romano M, Pilloni AP, Giordano B, Montella F, Caliendo S, et al. Prevalence of antimicrobial resistance in eighty clinical isolates of H. pylori. Chemother 1999; 45: 8–14.
  • Evans DG, Queiros DMM, Mendes EN, Evans DJ. H. pylori cagA statusand s andm alleles ofvacA in isolates from individuals with a variety of H. pylori-associatted gastritic diseases. J Clin Microbiol 1998; 11: 3435–7.
  • Atherton JC, Cao P, Peek RM, Tummuru MKR, Blaser MJ, Cover TL. Mosaicism in vacuolating cytotoxin alleles of H. pylori. J Biol Chem 1995; 30: 17771–7.
  • van Doorn LJ, Figueiredo C, Sanna R, Pena S, Midolo P, Ng EKW, et al. Expanding allelic diversity of H. pylori vacA. J Clin Microbiol 1998; 9: 2597–603.
  • van Doorn LJ, Figueiredo C, Sanna R, Plaiser A, Schneeberger P, df Boer W, et al. Clinical revalence of cagA, vacA and iceA status of H. pylori. Gastroenterology 1998; 115: 58–66.
  • Misiewicz CN, Tytgat CS, Goodwin CS, Price AB, Sipponen P, Strickland RG, et al. The Sydney system: a new classification of gastritis. Working Party Reports 1990: 1–10.
  • Glupczynski Y. Culture of Helicobacter pylori from gastric biopsies and antimicrobial susceptibility testing. In: Megraud F, Lee A, eds. H. pylori – techniques for clinical diagnosis & basic research. WB Saunders Co. Ltd, London 1996: 17–32.
  • Mclaren A. In vitro susceptibility testing of H. pylori. In: Clayton CL, Mobley HLT. Helicobacter pylori protocols. Humana Press Inc. 1997: 41–51.
  • Goodwin CS, Armstrong JA. Microbiological aspects of H. pylori. Eur J Clin Microbiol Infect Dis 1990; 1: 1–13.
  • State Agency of Medicines. Oral report, Tartu, 1999.
  • Lerang F, Moum B, Ragnhildstveit E, Haug JB. Helicobacter pylori infection and metronidazole resistance. Gut 1995; 1: A343.
  • Megraud F. Epidemiology and mechanism of antibiotic resistance in H. pylori. Gastroenterology 1998; 115: 1278–82.
  • Sebald M. Genetic basis for antibiotic resistance in anaerobes. Clin Infect Dis 1994; 18: S297–304.
  • Taylor DE, Ge Z, Purych D, Lo T, Hiratsuka K. Cloning and sequence analysis of two copies of a 23S rRNA gene from H. pylori and association of clarithromycin resistance with 23S rRNA mutations. Antimicrob Ag Chemother 1997; 12: 2621–8.
  • Stone GG, Shortridge D, Versalovic J, Beyer J, Flamm RK, Graham DY, et al. A PCR-oligonucleotide ligation assay to determine the prevalence of 23S rRNA gene mutations in clarithromycin-resistant Helicobacter pylori. Antimicrob Ag Chemother 1997; 3: 712–4.
  • Zanetti MV, Pieramico O, Mutschlechner A. H. pylori resistance to metronidazole and clarithromycin: is it related to the presence of CagA? Poster in 9th European Congress of Clinical Microbiology and Infectious Diseases, Berlin, 1999 Clinical Microbioogy and Infection, vol 5, suppl. 3: 260.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.